KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Goodwill & Intangibles: 2010-2024

Historic Goodwill & Intangibles for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to $501.5 million.

  • Emergent BioSolutions' Goodwill & Intangibles fell 12.57% to $452.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $452.7 million, marking a year-over-year decrease of 12.57%. This contributed to the annual value of $501.5 million for FY2024, which is 11.49% down from last year.
  • Emergent BioSolutions' Goodwill & Intangibles amounted to $501.5 million in FY2024, which was down 11.49% from $566.6 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Goodwill & Intangibles ranged from a high of $947.0 million in FY2022 and a low of $501.5 million during FY2024.
  • For the 3-year period, Emergent BioSolutions' Goodwill & Intangibles averaged around $671.7 million, with its median value being $566.6 million (2023).
  • Per our database at Business Quant, Emergent BioSolutions' Goodwill & Intangibles climbed by 14.17% in 2022 and then crashed by 40.17% in 2023.
  • Yearly analysis of 5 years shows Emergent BioSolutions' Goodwill & Intangibles stood at $929.8 million in 2020, then fell by 10.79% to $829.5 million in 2021, then grew by 14.17% to $947.0 million in 2022, then slumped by 40.17% to $566.6 million in 2023, then declined by 11.49% to $501.5 million in 2024.